Abstract
The objective of the PADIS-PE study was to determine whether patients with 1 episode of unprovoked pulmonary embolism would benefit from an additional 18 months of oral anticoagulant treatment. Age, residual perfusion defects, and residual deep vein thrombosis were found to be independent risk factors associated with recurrent venous thromboembolism.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
